ofloxacin has been researched along with fusidic acid in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Coste-Burel, M; Espaze, EP; Reynaud, AE; Richet, H | 1 |
| Van Caekenberghe, D | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Ajzen, H; Barbosa, D; Cendoroglo, M; Dalboni, A; Draibe, S; Parisio, K; Pignatari, A; Rabelo, T; Sesso, R | 1 |
| Argenson, JN; Drancourt, M; Groulier, P; Raoult, D; Roiron, R; Stein, A | 1 |
| Bryskier, A; Capper, T; Klugman, KP | 1 |
| Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
| Akiyama, H; Arata, J; Kanzaki, H; Tada, J; Yamasaki, O | 1 |
| Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
| Li, R; Liu, C; Sun, XG; Wang, ZQ | 1 |
| Fazeli, MR; Sepahi, AA; Shariatmadari, F; Zamani, N | 1 |
1 trial(s) available for ofloxacin and fusidic acid
| Article | Year |
|---|---|
Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Administration, Topical; Adult; Catheters, Indwelling; Female; Fusidic Acid; Humans; Male; Middle Aged; Nasal Mucosa; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Staphylococcal Infections; Staphylococcal Skin Infections | 1994 |
15 other study(ies) available for ofloxacin and fusidic acid
| Article | Year |
|---|---|
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
Topics: Bone Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fusidic Acid; Humans; In Vitro Techniques; Joint Diseases; Methicillin; Methicillin Resistance; Ofloxacin; Pefloxacin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 1992 |
Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp.
Topics: Anti-Infective Agents; Ciprofloxacin; Fusidic Acid; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Species Specificity | 1990 |
Streptococcus faecalis: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Topics: Animals; Anti-Bacterial Agents; Blood; Cattle; Enterococcus faecalis; Fibrin; Fusidic Acid; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Penicillins; Rabbits; Thienamycins; Vancomycin | 1986 |
Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Middle Aged; Ofloxacin; Orthopedic Fixation Devices; Rifampin; Staphylococcal Infections | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Streptococci isolated from various skin lesions: the interaction with Staphylococcus aureus strains.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Erythromycin; Fluoroquinolones; Fusidic Acid; Humans; Imipenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillins; Skin Diseases, Bacterial; Species Specificity; Streptococcal Infections; Streptococcus; Vancomycin | 1999 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
[Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
Topics: Anti-Bacterial Agents; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Tobramycin; Vancomycin | 2009 |
A new probiotic Lactobacillus plantarum strain isolated from traditional dairy together with nanochitosan particles shows the synergistic effect on aflatoxin B1 detoxification.
Topics: Aflatoxin B1; Anti-Bacterial Agents; Chitosan; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Lactobacillales; Lactobacillus plantarum; Nalidixic Acid; Neomycin; Ofloxacin; Probiotics; Vancomycin | 2022 |